What are Near-infrared fluorescent imaging agent drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Near-infrared fluorescent imaging agent drugs are pharmacologic agents that share a common mechanism (typically targeting Indocyanine green (ICG) dye — no specific receptor target; acts as a fluorophore). 0 are currently marketed, with 2 more in clinical development.

Near-infrared fluorescent imaging agent

0 marketed 2 in Phase 3

This page covers all Near-infrared fluorescent imaging agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Indocyanine green (ICG) dye — no specific receptor target; acts as a fluorophore.

Targets

Indocyanine green (ICG) dye — no specific receptor target; acts as a fluorophore

Phase 3 pipeline (2)

IC-Green KIT · Milton S. Hershey Medical Center · Surgery/Surgical imaging
IC-Green is a near-infrared fluorescent dye that emits light in the near-infrared spectrum when excited by appropriate wavelengths, enabling real-time visualization of tissue perfusion and vascular structures during surgical procedures.
ICG (Indocyanine Green) · Fujian Medical University Union Hospital · Surgical imaging / Diagnostic imaging
Indocyanine green is a near-infrared fluorescent dye that emits light when excited by near-infrared wavelengths, enabling real-time visualization of tissues and blood vessels during surgical and diagnostic procedures.

Patent intelligence

near infrared fluorescent imaging agent patent landscape — aggregated cliff calendar, attackable patents, originator estates